February VOICE is here!

Announcing the new ovarian rejuvenation study, rescue in vitro maturation (R-IVM) for poor-prognosis patients, a patient pays a visit 15 years later, and more. Read it here.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.